drugset / Trial / NCT02590497

Correlation Between the Genetic and Neuroimaging Signatures in Newly Diagnosed Glioblastoma Patients Before Surgery

NCT02590497

NaSingle-groupOpen-labelDiagnostic

Summary

This pilot clinical trial studies the correlation between the genetics and brain images of patients with newly diagnosed glioblastoma before surgery. The genetic characteristics of a tumor are an important way to predict how well it will respond to treatment. Imaging, using magnetic resonance imaging (MRI), takes detailed pictures of organs inside the body, and may also provide information that helps doctors predict how brain tumors will respond to treatment. If MRI can provide doctors with similar information about the tumor as the tumor's genes, it may be able to be used to predict tumor response in patients whose tumors cannot be reached by surgery or biopsy to get tissue samples.

Timeline

Start
2016-03-20
Primary completion
2017-10-26
Completion
2017-10-26

Drugs

EvaluationDrugModalityDoseRoute
Background Gadolinium Diagnostic / imaging agent

Indications